Before you blame yourself, let's see what's really happening.
Most people using a GLP-1 medication don't reach their real plateau — the point where weight loss actually stops — until 12 to 24 months in.1 If you're earlier than that and the scale isn't moving, it's very likely something else — something specific you can check. This guide covers the most common reasons, starting with the most likely one. This is about biology, not willpower — but which biology it is depends on your timing.
A true weight plateau is a physiological state, not a feeling: the point where the calories your body burns and the calories you take in settle into balance, so your weight holds steady even though you're still doing everything the same way. In GLP-1 research, this typically emerges 12 to 24 months into treatment, once the medication's appetite-suppressing effect and your body's own hunger-driving response settle into a new equilibrium.
Most of what people call a "plateau" earlier than that isn't one. It's a stall — a shorter flat stretch, days to a few weeks, usually caused by water retention, measurement noise, or a dose that hasn't finished increasing yet. Stalls resolve on their own. A true plateau doesn't, without a deliberate change.
This is the general research pattern, not your personal chart — most flat scales happen early, and the real plateau usually lands much later than people expect.
I won't promise you a certain number by a certain date. Everyone's body moves at its own pace. I'll check in each week and let you know if it's ever a good time to see your doctor.
How to tell a short-term slow-down from a longer stall
A flat scale by itself doesn't tell you enough. Here's what else to look at, so you're not guessing whether to keep going or make a change.
It depends where you are. If your dose is still increasing, this is usually just timing — your appetite hasn't been fully lowered yet. If you're further along, a flat scale is often because you're gaining muscle while losing fat at the same time. Muscle is denser than fat, so the scale doesn't show the change even though your body is. Your waist size and strength tell you what the scale can't. Clarity checks all of this every week, so a flat number doesn't push you to cut food when you're actually doing well.
See Clarity membershipFind out what's causing your stall
You may already have a guess, from your own research or your doctor. These questions ask about your dose, your training, and your body — so what we suggest next fits your real situation instead of generic advice. Be honest; your answers stay on your device.
- Hall KD. A mathematical model of energy balance predicting body weight, appetite, and metabolic adaptation to GLP-1 receptor agonists. Obesity. 2024;32(6):1163-1168.
- Oelmann C, et al. Weight-loss resistance in resistance-trained women across the menopause transition. J Int Soc Sports Nutr. 2025;22(sup2), n=1,686.
- Network meta-analysis of 22 RCTs (2024); Beavers et al., Obesity 2025 (9 RCTs); DXA substudies. Resistance training plus protein lowers the lean-mass share of weight lost.
- Wilding JPH, et al. STEP 1 trial design, NEJM 2021; extension, Diabetes Obes Metab 2022 — standard semaglutide dose escalation runs ~16 weeks to maintenance dose.
- Ioannidou A, et al. 20-week RCT — postmenopausal women needed higher resistance-training volume (>6–8 sets/muscle/week) than premenopausal women to see comparable hypertrophy.
Where does the lost weight actually come from?
Not everything you lose is fat. Some of it is muscle — and you have some control over how much.
- A higher daily calorie burn
- Better strength and mobility
- Improved insulin sensitivity
- A better chance of maintaining their weight loss over time
How we figure out what's really happening
Each week, Kenning looks at what you share — your waist, protein, strength, and sleep — and needs about 14 days of information to tell a real pattern apart from normal day-to-day ups and downs. The more you share, the sooner and clearer your answer will be.
Deciding what you'll do ahead of time works better than relying on willpower in the moment. Finish the sentence below right now, before you start Day 1. Set it once — don't come back and fill it in later, it works best when it's decided in advance.
- Check in once a day, most days — it takes seconds, not minutes.
- Three days are marked Key Day — do those three even if you skip the rest.
- Tap a day below to open it. Only one day is open at a time, so you're never staring at all 14 at once.
- After Day 14, come back to the top of this page — Mei will have a clear read on your pattern.
Reached Day 14? How did it go?
Tell us honestly, and we'll tell you what to do next: keep going, start another check-in cycle, or talk to your prescriber.
Your waist or scale moved, which means your plan is working. Kenning now steps back to a weekly check-in: we'll keep watching what you share, so your next stall gets caught early. Keep doing what you're doing — nothing else to change right now.
You're making progress but not finished, so let's keep it up. Your next check-in cycle is the same plan, one step further: 3 strength sessions instead of 2, more consistent protein timing, and one day eating at maintenance calories partway through. We'll keep tracking your progress and let you know when you've resolved your stall.
This isn't a sign to cut your food further — eating less at this point tends to cost you muscle and can make things worse. It's time to bring your prescriber into the conversation. Take these questions with you:
- "My weight and waist have been flat for 2+ weeks, even though I've been hitting my protein and strength training goals."
- "Am I on the right dose, or is there room to adjust it?"
- "Could my appetite be low enough that I'm not eating enough, and losing muscle because of it?"
- "Would a different GLP-1 medication be worth trying for me?"
- "Can we check my thyroid (TSH), iron levels (ferritin), and blood sugar (HbA1c) to rule out other causes?"
Your wins — not just the scale
During a stall, the scale is the least useful number you have. Enter these measurements and we'll show you what's actually happening in your body.
What to check weekly (not every day)
The evidence, in the open
The research behind your plan — how common this is, what the real timeline looks like, and what the studies actually show. You don't need to read any of this to follow your weekly plan; it's here if you want to see the evidence. We also point out what science still doesn't know for sure.
When does a real plateau actually happen?
We checked this before writing anything else in this guide.
- A 2024 study built a mathematical model using data from real GLP-1 drug trials (semaglutide and tirzepatide). It found that weight loss usually keeps going, without a clear stopping point, until well past 12 months — often closer to 24 months. That's a similar timeline to weight-loss surgery.1
- By comparison, people who lose weight through diet alone tend to plateau earlier, around 12 months. Here's why GLP-1s are different: your body has a natural system that fights weight loss by making you hungrier. Diets don't change that system much, but GLP-1 medications turn down that hunger response for a while — which is why the real plateau takes longer to show up.1
- In plain terms: if you're only a few weeks or months in and the scale has stopped moving, this is almost certainly not your body's real, long-term plateau. It's much more likely to be your dose still increasing, or one of the other checkable reasons on the previous page.
How common this is
It might feel like everyone is on a GLP-1 medication lately — and the numbers back that up, especially for women in midlife.
- About 1 in 8 US adults is currently using a GLP-1, and roughly 1 in 5 has ever tried one — up 587% since 2019.15
- Women 50–64 are the single highest-using group (~1 in 5). Women use these medicines more than men at almost every age.15
- So a stall isn't a personal failure that only happens to you — millions of women your age are going through the same thing.
The dose ramp-up before any plateau
Before you can plateau, your dose has to finish increasing — and that takes longer than most people expect.
- Semaglutide (a common GLP-1 medication) usually raises your dose every 4 weeks, in 4 steps, taking about 16 weeks to reach your full dose.2 Other GLP-1 medications follow a similar step-up pattern — check your exact schedule with your prescriber.
- Until you reach your full dose, your appetite hasn't been lowered as much as it will be. A flat scale during this window is usually just timing, not a plateau.
What the weight-loss timeline actually looks like
Weight loss is fast at first, then slows down — later than most people expect. This slowing is a normal, built-in part of how these medications work.
- In the longest trial, weight loss leveled off around week 60 (about month 14) and then held steady at about 15% total weight lost for two years. This fits the later-timeline explanation above — it doesn't contradict it.4
- Tirzepatide (another GLP-1 medication) tends to level off a bit earlier, around 24 to 36 weeks, depending on the person's starting weight — still within the early stages, not the true long-term plateau.4
- In everyday use, outside of a research trial, people tend to lose somewhat less than in trials — about 8.7% of body weight at one year on average, often because their actual dose ends up lower than the trial dose.5
Where does the lost weight actually come from?
Not everything you lose is fat. Some of it is muscle — and you have some control over how much.
See the full breakdown, in kilograms, in the Where You Are section.
- Across studies, roughly a quarter to a third of the weight lost on a GLP-1 is muscle, not fat (about 25–31%, up to 40% in some body-scan studies).6
- With strength training and enough protein, that share drops to about 15 to 20% — meaning more of what you lose is fat.6
- After menopause, women often need more strength training than before to build the same amount of muscle — more than 6 to 8 sets per muscle group each week, in one study.8
- Losing muscle slows down the number of calories your body burns at rest, which is one reason a stall can get worse over time. Protecting your muscle is the thing you have the most control over.9,12
What else can cause a stall
Once you've ruled out your dose still increasing and normal week-to-week changes: it's rarely just one thing.
- Not enough strength training. In one study of postmenopausal women, strength training plus a higher-protein diet improved both body composition and strength.8
- This is common in midlife. A 2025 study of 1,686 women who did strength training found that 67.3% of premenopausal, 74.6% of perimenopausal, and 80.1% of postmenopausal women said their weight resisted change.7
- Falling estrogen. During perimenopause and after menopause, lower estrogen tends to slow your metabolism, shift fat toward your midsection, and make your body less sensitive to insulin (the hormone that manages blood sugar).13
- Stress and poor sleep. These raise cortisol (a stress hormone) and make it harder for your body to repair muscle. At the same calorie intake, people who sleep longer tend to lose more fat.13
- A true plateau. After real weight loss, your body can burn somewhat fewer calories at rest, and this can last a year or more. This is the mechanism behind the late-stage plateau described above — it's just less likely to be the main cause this early.1,12
- One more possible explanation, not yet proven for GLP-1s: in studies of diet-only weight loss, the main reason people plateaued early was that they weren't sticking to their plan consistently — not a slowdown in their body. This evidence comes from diet studies, not GLP-1 studies, so we're naming it as a possibility, not a settled fact.10
Your 14-day plan, step by step, and why
The same plan from the "Where you are, and what's next" page, with the reasoning behind each step.
| When | Do this | Why — and the evidence |
|---|---|---|
| Week 1 Days 1–7 |
Eat protein early (30 g+ at breakfast). Measure your waist, not just your weight. Start strength training 2×/week. Take a 20-minute walk after your largest meal. | Protein and strength training help you keep the muscle that keeps your metabolism up;6,9 your waist shows fat loss even when the scale doesn't. The World Health Organization recommends strength training 2×/week for all adults.9 |
| Week 2 Days 8–14 |
Keep protein at about 1.2 to 1.6 g per kilogram of a healthy goal weight, spread across meals. Increase strength training to 3×/week, using bigger movements that work several muscles at once. Take one day at maintenance calories (eating enough to hold your weight, not lose). Creatine, about 5 g/day, is optional. | A day at maintenance calories can ease some of the hormonal pushback your body builds up during a long stretch of eating less;12 spreading protein across meals raises muscle-building by about 25%;14 creatine is one of the best-studied supplements for keeping muscle.14 |
| Day 14+ if still flat |
Don't cut your food further. Bring your prescriber the visit script below. | Eating less at this point tends to cost you muscle and can make the stall worse. Reviewing your dose or medication with your prescriber is more likely to help than eating less.5 |
If you stop your GLP-1 without a plan, research shows most people regain a large part of the weight they lost. In one trial, people who stopped semaglutide after 68 weeks regained about 63% of their lost weight within a year of stopping. People who stopped earlier, at 20 weeks, regained about 50%.2,3
We're not telling you this to scare you — we're telling you because it's true, and because it means holding onto your weight loss is a real win, not just "not losing more." Reaching Stage 4 (weight holding steady) isn't the finish line. It's an ongoing stage that needs its own plan, just like losing the weight did.
- The 16-week dose schedule is a general estimate, not specific to one brand — your actual schedule depends on your exact medication and your prescriber's plan.
- The "not sticking to the plan" explanation for early stalls comes from studies of diet-only weight loss, not a GLP-1 trial — we're naming it as one possible explanation, not a proven one.10
- The 12–24 month window for the real plateau comes from averaging across many people, not a prediction for any one person — treat it as a general guide, not a personal deadline.1
- There's no official protein target specifically for GLP-1 users from controlled research trials yet — today's numbers are borrowed from broader weight-loss research.6
- Studies combining GLP-1 medication with strength training are still new; the exact numbers on protecting muscle will likely get more precise.
- We don't have plateau research specific to different ethnic groups. Kenning uses different waist and weight targets for Asian bodies based on general health research — not a claim that the plateau itself works differently.
- Real-world data on side effects and who stops treatment, and why, is still limited, in the researchers' own words.15
- Hall KD. A mathematical model of energy balance predicting body weight, appetite, and metabolic adaptation to GLP-1 receptor agonists. Obesity. 2024;32(6):1163-1168 — fit to STEP/SURMOUNT data; GLP-1 plateau timing extends to ~24 months vs. ~12 months for diet alone.
- Wilding JPH, et al. STEP 1, NEJM 2021 (trial design: ~16-week dose escalation); extension, Diabetes Obes Metab 2022 — 63% of lost weight regained within 1 year of stopping semaglutide at 68 weeks.
- Rubino D, et al. STEP 4, JAMA 2021 — 50% of lost weight regained within 1 year of stopping semaglutide at 20 weeks.
- Garvey WT, et al. STEP 5, Nat Med 2022 — semaglutide plateaus ~week 60, holds at 15.2% through 104 weeks; SURMOUNT-1/-4 — tirzepatide plateau ~24–36 weeks by BMI.
- Real-world cohort, Obesity 2025 (Cleveland Clinic) — mean 1-year loss 8.7%; ≥12-month persistence median 14.4%.
- Network meta-analysis, 22 RCTs (2024); Beavers et al., Obesity 2025 (9 RCTs, 30.8%); DXA substudies 26–40%. Resistance training plus protein lowers the lean share toward 15–20%.
- Oelmann C, et al. Weight-loss resistance in resistance-trained women across the menopause transition. J Int Soc Sports Nutr. 2025;22(sup2), n=1,686 — 67.3% / 74.6% / 80.1% pre/peri/postmenopausal.
- Ioannidou A, et al. 20-week RCT (PMC10559623) — postmenopausal women need >6–8 sets/muscle/week for hypertrophy seen at lower volume premenopause; 12-week RCT, J Nutr Health Aging 2024 — resistance training + ~2.5 g/kg fat-free-mass protein improved body composition and strength postmenopause.
- Thomas E, et al. Aging Clin Exp Res. 2021;33:2941-2952 (745 women); World Health Organization physical-activity guidelines, 2020.
- Thomas DM, et al. Am J Clin Nutr. 2014 (PMC4135489) — modeling against CALERIE/NHANES data found intermittent lack of adherence, not metabolic adaptation, was the main driver of early diet-only plateaus.
- Dynamic Energy Balance review (PMC6513301) — early rapid weight loss includes fat-free mass (glycogen, protein, fluid), not just fat.
- Rosenbaum M, Leibel RL. Int J Obes. 2010 — adaptive thermogenesis persists a year or more after weight loss.
- Menopause metabolic reviews (Aging Clin Exp Res 2021; 2025–2026) — estrogen decline, ~0.6%/yr muscle loss, cortisol, short sleep, and thyroid dysfunction.
- Mamerow MM, et al. J Nutr. 2014 (protein distribution +~25% synthesis); Rubin KH et al., international consensus 2025 (1.2–1.6 g/kg); Rawson ES et al., Sports Med 2011 (creatine ~5 g/day).
- KFF Health Tracking Poll (2025); Gallup National Health & Well-Being Index (2025); RAND American Life Panel (2025); FAIR Health (2024): GLP-1 use for overweight/obesity rose 587% from 2019–2024.
If you want a second opinion
Most stalls resolve on their own within a couple of weeks of consistent protein and strength training. This page isn't here because a plateau means you need a doctor — it's here for the minority of cases where a second set of eyes is genuinely useful, or if you'd simply feel better looping your prescriber in.